Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance

Hepatocellular carcinoma (HCC) is a common malignancy and a leading cause of cancer-related mortality. Current guidelines and staging systems provide coarse categories, but often miss within-stage heterogeneity and the clinical context in electronic medical records (EMRs). We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model that reads routine EMR narratives and jointly outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates. We curated about 30,000 HCC cases from SEER and expanded them into EMR-style narrative training data using a clinician-validated, prompt-based augmentation workflow. On this corpus, we developed a knowledge-aligned reasoning framework optimized with a step-verifiable composite reward, moving beyond text-level memorization of clinical guidelines. In a multi-center cohort of 6,668 patients from 12 hospitals in China, HCC-STAR achieved state-of-the-art performance in treatment recommendation and risk stratification compared with clinical guidelines and competitive models, including GPT-5 and Gemini-2.5 Pro. Hypothetical overall-survival analysis showed a median survival of 51 months under adherence to HCC-STAR recommendations, compared with 29 and 32 months under BCLC and CNLC. In clinician-centric evaluations, blinded hepatobiliary specialists rated HCC-STAR's reasoning and evidence-based justifications as trustworthy. The model surpassed resident and attending physicians in treatment accuracy and helped physicians make more accurate decisions faster when used as an assistant. These findings support HCC-STAR as a reliable and verifiable decision-support system for risk stratification and precision therapy in HCC.

MAVE: A Product Dataset for Multi-source Attribute Value Extraction

Attribute value extraction refers to the task of identifying values of an attribute of interest from product information. Product attribute values are essential in many e-commerce scenarios, such as customer service robots, product ranking, retrieval and recommendations. While in the real world, the attribute values of a product are usually incomplete and vary over time, which greatly hinders the practical applications. In this paper, we introduce MAVE, a new dataset to better facilitate research on product attribute value extraction. MAVE is composed of a curated set of 2.2 million products from Amazon pages, with 3 million attribute-value annotations across 1257 unique categories. MAVE has four main and unique advantages: First, MAVE is the largest product attribute value extraction dataset by the number of attribute-value examples. Second, MAVE includes multi-source representations from the product, which captures the full product information with high attribute coverage. Third, MAVE represents a more diverse set of attributes and values relative to what previous datasets cover. Lastly, MAVE provides a very challenging zero-shot test set, as we empirically illustrate in the experiments. We further propose a novel approach that effectively extracts the attribute value from the multi-source product information. We conduct extensive experiments with several baselines and show that MAVE is an effective dataset for attribute value extraction task. It is also a very challenging task on zero-shot attribute extraction. Data is available at {\it \url{https://github.com/google-research-datasets/MAVE}}.